MedTrace Logo

COVID-19 Testing Pilot Study

NCT04843878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 326

Last updated 2021-04-14

No results posted yet for this study

Summary

The purpose of this study is to determine the reliability of a low-cost rapid diagnostic test for COVID-19. The method of the testing procedure uses electrochemistry to detect COVID-19 spike proteins within human samples. To test the effectiveness of this new method, patients will be recruited as they present for testing at ambulatory Penn testing sites. Patients will be asked to self-collect one anterior nares samples under the supervision of authorized study personnel.

Conditions

  • Diagnostic Test, Routine
  • Coronavirus
  • Diagnoses Disease
  • Rapid Coronavirus Test

Interventions

DIAGNOSTIC_TEST

COVID Detect

The study is determining the efficacy of a new rapid COVID testing method.

Sponsors & Collaborators

  • Benjamin S. Abella, MD, MPhil

    collaborator UNKNOWN

  • Marcelo Der Torossian Torres, Ph.D.

    collaborator UNKNOWN

  • Cesar De La Fuente, Ph.D.

    collaborator UNKNOWN

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Benjamin S Abella, MD, MPhil · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-05
Primary Completion
2021-03-12
Completion
2021-03-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04843878 on ClinicalTrials.gov